Compass Pathways Plc - ADR Stock
$4.59
3.57%
yesterday
Nasdaq,
Jun 11, 10:00 pm CET
Compass Pathways Plc - ADR Stock price
$4.59
+0.68
17.39%
1M
+0.06
1.32%
6M
+0.81
21.43%
YTD
-1.80
28.17%
1Y
-12.41
73.00%
5Y
-12.41
73.00%
10Y
-12.41
73.00%
20Y
Nasdaq,
Closing price Wed, Jun 11 2025
-0.17
3.57%
Powered by
Key metrics
| Market capitalization | $441.96m |
| Enterprise Value | $212.39m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 2.18 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-189.25m |
| Free Cash Flow (TTM) Free Cash Flow | $-144.02m |
| Cash position | $260.11m |
Show more
Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,836 stocks worldwide.
Compass Pathways Plc - ADR Stock Analysis
Unlock Scores for Free
Analyst Opinions
10 Analysts have issued a Compass Pathways Plc - ADR forecast:
Analyst Opinions
10 Analysts have issued a Compass Pathways Plc - ADR forecast:
Buy
100%
Financial data from Compass Pathways Plc - ADR
| Mar '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -189 -189 |
42%
42%
|
EBIT (Operating Income) EBIT | -189 -189 |
42%
42%
|
| Net Profit | -138 -138 |
6%
6%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Compass Pathways Plc - ADR Stock News
Neutral
Business Wire
●
29 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference at 10:30 am ET on May 20th, 2025. A live audio webcast of the pr...
Neutral
Seeking Alpha
●
about one month ago
COMPASS Pathways plc (NASDAQ:CMPS ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Steve Schultz - SVP, IR Kabir Nath - CEO Teri Loxam - CFO Guy Goodwin - Chief Medical Officer Steve Levin - Chief Patient Officer Conference Call Participants Paul Matteis - Stifel Charles Duncan - Cantor Fitzgerald Athena Chin - TD Cowen Sumant Kulkarni - Canaccord Genuity Patrick T...
Neutral
Business Wire
●
about one month ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2025 and provided an update on recent progress across its business. “We eagerly await the upcoming topline 6-week data readout, on tra...
Company Profile
| Head office | United Kingdom |
| CEO | Kabir Nath |
| Employees | 166 |
| Founded | 2016 |
| Website | compasspathways.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
